Ambryx Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Out of Business

Ambryx General Information

Description

Operator of a biotechnology company intended to focus on discovering new cancer therapeutics. The company's platform uses a combination of phenotypic screening of embryonic proteins and iterative library mapping, enabling researchers to find drugs to kill embryonic proteins which can selectively cause cancer cells.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1200 Columbia Avenue
  • Riverside, CA 92507
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 1200 Columbia Avenue
  • Riverside, CA 92507
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ambryx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 10-Dec-2018 Completed Out of Business
3. Accelerator/Incubator 01-Jan-2016 Completed Startup
2. Grant 01-Jan-2013 $317K $12.3M Completed Startup
1. Early Stage VC (Series A) 25-Oct-1999 $12.3M $12.3M Completed Startup
To view Ambryx’s complete valuation and funding history, request access »

Ambryx Patents

Ambryx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201811726-D0 Therapeutic compositions Inactive 18-Jul-2018
CA-2731463-A1 Compositions and methods for increasing serum antioxidant concentrations Inactive 25-Jul-2008
EP-2323682-A2 Compositions and methods for increasing serum antioxidant concentrations Active 25-Jul-2008
EP-2323682-A4 Compositions and methods for increasing serum antioxidant concentrations Active 25-Jul-2008
WO-2010011533-A2 Compositions and methods for increasing serum antioxidant concentrations Inactive 25-Jul-2008 A61K38/1709
To view Ambryx’s complete patent history, request access »

Ambryx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ambryx FAQs

  • When was Ambryx founded?

    Ambryx was founded in 1997.

  • Where is Ambryx headquartered?

    Ambryx is headquartered in Riverside, CA.

  • What is the size of Ambryx?

    Ambryx has 3 total employees.

  • What industry is Ambryx in?

    Ambryx’s primary industry is Biotechnology.

  • Is Ambryx a private or public company?

    Ambryx is a Private company.

  • What is Ambryx’s current revenue?

    The current revenue for Ambryx is .

  • How much funding has Ambryx raised over time?

    Ambryx has raised $12.3M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process